Abstract
Current ProtocolsVolume 3, Issue 5 e470 ISSUE INFORMATIONFree Access Issue Information First published: 29 May 2023 https://doi.org/10.1002/cpz1.470AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Graphical Abstract Cover: A chemically-defined cardiac spheroid comprised of human induced pluripotent stem cell (hiPSC)-derived cardiomyocytes (red) and hiPSC-derived endothelial cells. These separate hiPSC-derived cell types are differentiated separately and then aggregated in chemically-defined conditions to create a three-dimensional model of cardiac function. The protocol is described in this issue by Artz et al. View all latest articles RelatedInformation
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
